IQVIA Holdings Inc.

IQV ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $16.31B $15.41B $14.98B $14.41B $13.87B $11.36B $11.09B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $2.00B $1.99B $2.05B $2.07B $1.96B $1.79B $1.73B
Operating Income $2.18B $2.20B $1.98B $1.80B $1.39B $731.0M $777.0M
Operating Margin 13.4% 14.3% 13.2% 12.5% 10.0% 6.4% 7.0%
Interest Expense $729.0M $670.0M $672.0M $416.0M $375.0M $416.0M $447.0M
Pretax Income $1.59B $1.67B $1.46B $1.36B $1.13B $373.0M $352.0M
Income Tax Expense $252.0M $301.0M $101.0M $260.0M $163.0M $72.0M $116.0M
Net Income $1.36B $1.37B $1.36B $1.09B $966.0M $279.0M $191.0M
Net Margin 8.3% 8.9% 9.1% 7.6% 7.0% 2.5% 1.7%
EPS (Basic) $7.91 $7.57 $7.39 $5.82 $5.05 $1.46 $0.98
EPS (Diluted) $7.84 $7.49 $7.29 $5.72 $4.95 $1.43 $0.96
Shares Outstanding (Basic) 169.7M 171.9M 181.3M 183.8M 187.6M 191.4M 191.3M 195.1M
Shares Outstanding (Diluted) 169.7M 173.5M 183.4M 186.3M 190.6M 195.0M 195.0M 199.6M
Dividends Per Share
← Newer Page 1 of 3 Older →